Kester Capital’s Evestia Clinical acquires Atlantic Research Group
July 2025
Kester Capital grows investment team with a new hire
June 2025
Evestia Clinical - the new brand identity for EMAS Pharma
March 2025
Kester Capital backs leading software provider Re-flow
March 2025
Kester Capital announces promotions
February 2025
Kester-backed DC Byte announces leadership evolution
February 2025
The MAP Group is pleased to announce it is rebranding as Kintiga
January 2025
The Boundary appoints Simon Ward as Chairman
January 2025
A hat trick of nominations at the Real Deals Private Equity Awards 2025
January 2025
Kester Capital completes carve-out of Evestia Clinical (formerly EMAS Pharma)
December 2024
Kester Capital sells Atec realising fourth consecutive exit over 4x
August 2024
Kester Capital backs management buy-out of The Boundary
July 2024
Kester Capital’s GXP Engaged acquires SwissPharmAudit
June 2024
Kester Capital agrees sale of Atec
June 2024
Kester Capital’s Kintiga (formerly MAP Patient Access) enters German market through acquisition of SKC
May 2024
Kester Capital wins ‘PE House of the Year – Small-Cap’ at the 2024 Real Deals Private Equity Awards
April 2024
Kester Capital’s GXP Engaged acquires Polaris Compliance Consultants
April 2024
Kester Capital closes oversubscribed Kester Capital III at £200 million hard cap
March 2024
Kester Capital sells Jollyes, UK’s second largest pet retailer, for 4.3x return
February 2024
Kester Capital announces new hires alongside promotions and formation of charitable foundation
October 2023